Publicaciones en las que colabora con Ana López Real (7)

2007

  1. Angiotensin type-1-receptor antagonists reduce 6-hydroxydopamine toxicity for dopaminergic neurons

    Neurobiology of Aging, Vol. 28, Núm. 4, pp. 555-567

2005

  1. Angiotensin-converting enzyme inhibition reduces oxidative stress and protects dopaminergic neurons in a 6-hydroxydopamine rat model of Parkinsonism

    Journal of Neuroscience Research, Vol. 81, Núm. 6, pp. 865-873

2003

  1. Interaction between the noradrenergic and serotonergic systems in locomotor hyperactivity and striatal expression of Fos induced by amphetamine in rats

    Experimental Brain Research, Vol. 153, Núm. 1, pp. 92-99

  2. Localization and functional significance of striatal neurons immunoreactive to aromatic L-amino acid decarboxylase or tyrosine hydroxylase in rat Parkinsonian models

    Brain Research, Vol. 969, Núm. 1-2, pp. 135-146

2002

  1. Effects of (-)-nicotine and (-)-cotinine on 6-hydroxydopamine-induced oxidative stress and neurotoxicity: Relevance for Parkinson's disease

    Biochemical Pharmacology, Vol. 64, Núm. 1, pp. 125-135

  2. Effects of aluminum and zinc on the oxidative stress caused by 6-hydroxydopamine autoxidation: Relevance for the pathogenesis of Parkinson's disease

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1586, Núm. 2, pp. 155-168

2001

  1. Rat brain cholinergic, dopaminergic, noradrenergic and serotonergic neurons express GABAA receptors derived from the α3 subunit

    Receptors and Channels, Vol. 7, Núm. 6, pp. 471-478